MedTrace Logo

CoQ10 in Statin-associated Asthenia

NCT06391606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-30

No results posted yet for this study

Summary

This was a double-blind, randomized, placebo-controlled clinical study aiming to assess the effects of supplementation with CoQ10 phytosome on physical performance in older adults with self-reported statin-associated asthenia.

Conditions

Interventions

DIETARY_SUPPLEMENT

Coenzyme Q10

2 pills/day of 150 mg CoQ10 phytosome (i.e. 300 mg CoQ10 phytosome per day)

OTHER

Placebo

2 pills/day

Sponsors & Collaborators

  • University of Bologna

    lead OTHER

Principal Investigators

  • Claudio Borghi, MD, PhD · University of Bologna

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-03-01
Completion
2019-03-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06391606 on ClinicalTrials.gov